Completed
Bypass Angioplasty Revascularization Investigation (BARI)
Led by National Heart, Lung, and Blood Institute (NHLBI) · Updated on 2016-05-13
N/A
Participants Needed
N/A
Research Sites
917 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To assess the relative long-term safety and efficacy of percutaneous transluminal coronary angioplasty (PTCA) and coronary artery bypass graft (CABG) surgery in patients with multivessel disease and severe angina or ischemia who required revascularization and had coronary anatomy suitable for either procedure.
CONDITIONS
Official Title
Bypass Angioplasty Revascularization Investigation (BARI)
Who Can Participate
Eligibility Criteria
You may qualify if you...
Multivessel coronary artery disease requiring revascularization and suitable for either PTCA or CABG.
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
Trial Site Locations
Site Locations not provided
Location information for this trial is currently unavailable.
How is the study designed?
Study Type
INTERVENTIONAL
Masking
N/A
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here